201 related articles for article (PubMed ID: 28338293)
41. Association of long non-coding RNA H19 and microRNA-21 expression with the biological features and prognosis of non-small cell lung cancer.
Zhou Y; Sheng B; Xia Q; Guan X; Zhang Y
Cancer Gene Ther; 2017 Aug; 24(8):317-324. PubMed ID: 28799568
[TBL] [Abstract][Full Text] [Related]
42. LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis.
Xie X; Liu HT; Mei J; Ding FB; Xiao HB; Hu FQ; Hu R; Wang MS
Int J Clin Exp Pathol; 2014; 7(12):8881-6. PubMed ID: 25674259
[TBL] [Abstract][Full Text] [Related]
43. Analysis of lncRNA expression profiles in non-small cell lung cancers (NSCLC) and their clinical subtypes.
Yang J; Lin J; Liu T; Chen T; Pan S; Huang W; Li S
Lung Cancer; 2014 Aug; 85(2):110-5. PubMed ID: 24906504
[TBL] [Abstract][Full Text] [Related]
44. LncRNA HOXA11-AS promotes proliferation and invasion by targeting miR-124 in human non-small cell lung cancer cells.
Yu W; Peng W; Jiang H; Sha H; Li J
Tumour Biol; 2017 Oct; 39(10):1010428317721440. PubMed ID: 29034803
[TBL] [Abstract][Full Text] [Related]
45. A positive feedback loop between ZNF205-AS1 and EGR4 promotes non-small cell lung cancer growth.
He S; Lin J; Xu Y; Lin L; Feng J
J Cell Mol Med; 2019 Feb; 23(2):1495-1508. PubMed ID: 30556283
[TBL] [Abstract][Full Text] [Related]
46. Highly expressed long non-coding RNA FOXD2-AS1 promotes non-small cell lung cancer progression via Wnt/β-catenin signaling.
Rong L; Zhao R; Lu J
Biochem Biophys Res Commun; 2017 Mar; 484(3):586-591. PubMed ID: 28132805
[TBL] [Abstract][Full Text] [Related]
47. Down-regulation of long non-coding RNA MALAT1 by RNA interference inhibits proliferation and induces apoptosis in multiple myeloma.
Liu H; Wang H; Wu B; Yao K; Liao A; Miao M; Li Y; Yang W
Clin Exp Pharmacol Physiol; 2017 Oct; 44(10):1032-1041. PubMed ID: 28664617
[TBL] [Abstract][Full Text] [Related]
48. The role of lncRNA MALAT1 in bone metastasis in patients with non-small cell lung cancer.
Liu M; Sun W; Liu Y; Dong X
Oncol Rep; 2016 Sep; 36(3):1679-85. PubMed ID: 27431200
[TBL] [Abstract][Full Text] [Related]
49. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
[TBL] [Abstract][Full Text] [Related]
50. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.
Zhou M; Guo M; He D; Wang X; Cui Y; Yang H; Hao D; Sun J
J Transl Med; 2015 Jul; 13():231. PubMed ID: 26183581
[TBL] [Abstract][Full Text] [Related]
51. lncRNA-HIT promotes cell proliferation of non-small cell lung cancer by association with E2F1.
Yu L; Fang F; Lu S; Li X; Yang Y; Wang Z
Cancer Gene Ther; 2017 May; 24(5):221-226. PubMed ID: 28429752
[TBL] [Abstract][Full Text] [Related]
52. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
[TBL] [Abstract][Full Text] [Related]
53. Long non-coding RNA as potential biomarkers in non-small-cell lung cancer: What do we know so far?
Osielska MA; Jagodziński PP
Biomed Pharmacother; 2018 May; 101():322-333. PubMed ID: 29499406
[TBL] [Abstract][Full Text] [Related]
54. The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway.
Liu M; Zhou K; Huang Y; Cao Y
J Exp Clin Cancer Res; 2015 Oct; 34():121. PubMed ID: 26467212
[TBL] [Abstract][Full Text] [Related]
55. Long non-coding RNA linc00261 suppresses gastric cancer progression via promoting Slug degradation.
Yu Y; Li L; Zheng Z; Chen S; Chen E; Hu Y
J Cell Mol Med; 2017 May; 21(5):955-967. PubMed ID: 27878953
[TBL] [Abstract][Full Text] [Related]
56. Identification of long non-coding RNA 00312 and 00673 in human NSCLC tissues.
Tan Q; Yu Y; Li N; Jing W; Zhou H; Qiu S; Liang C; Yu M; Tu J
Mol Med Rep; 2017 Oct; 16(4):4721-4729. PubMed ID: 28849087
[TBL] [Abstract][Full Text] [Related]
57. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
[TBL] [Abstract][Full Text] [Related]
58. C5a induces A549 cell proliferation of non-small cell lung cancer via GDF15 gene activation mediated by GCN5-dependent KLF5 acetylation.
Zhao C; Li Y; Qiu W; He F; Zhang W; Zhao D; Zhang Z; Zhang E; Ma P; Liu Y; Ma L; Yang F; Wang Y; Shu Y
Oncogene; 2018 Aug; 37(35):4821-4837. PubMed ID: 29773900
[TBL] [Abstract][Full Text] [Related]
59. Identification of circulating long non-coding RNA GAS5 as a potential biomarker for non-small cell lung cancer diagnosisnon-small cell lung cancer, long non-coding RNA, plasma, GAS5, biomarker.
Tan Q; Zuo J; Qiu S; Yu Y; Zhou H; Li N; Wang H; Liang C; Yu M; Tu J
Int J Oncol; 2017 May; 50(5):1729-1738. PubMed ID: 28339045
[TBL] [Abstract][Full Text] [Related]
60. HOXA5 indicates poor prognosis and suppresses cell proliferation by regulating p21 expression in non small cell lung cancer.
Zhang ML; Nie FQ; Sun M; Xia R; Xie M; Lu KH; Li W
Tumour Biol; 2015 May; 36(5):3521-31. PubMed ID: 25549794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]